171 related articles for article (PubMed ID: 31617598)
1. Icariin-induced miR-875-5p attenuates epithelial-mesenchymal transition by targeting hedgehog signaling in liver fibrosis.
Ye L; Yu Y; Zhao Y
J Gastroenterol Hepatol; 2020 Mar; 35(3):482-491. PubMed ID: 31617598
[TBL] [Abstract][Full Text] [Related]
2. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p.
Kim J; Lee C; Shin Y; Wang S; Han J; Kim M; Kim JM; Shin SC; Lee BJ; Kim TJ; Jung Y
Mol Ther; 2021 Apr; 29(4):1471-1486. PubMed ID: 33348053
[TBL] [Abstract][Full Text] [Related]
3. miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression.
Qiu J; Wu S; Wang P; Zhou Y; Wang Z; Sun Y; Jiang C
Hepatol Int; 2023 Apr; 17(2):463-475. PubMed ID: 36001230
[TBL] [Abstract][Full Text] [Related]
4. miR-324-5p is up regulated in end-stage osteoarthritis and regulates Indian Hedgehog signalling by differing mechanisms in human and mouse.
Woods S; Barter MJ; Elliott HR; McGillivray CM; Birch MA; Clark IM; Young DA
Matrix Biol; 2019 Apr; 77():87-100. PubMed ID: 30193893
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis.
Du Z; Wu T; Liu L; Luo B; Wei C
J Cell Mol Med; 2021 Jan; 25(2):701-715. PubMed ID: 33342075
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-125a-5p Contributes to Hepatic Stellate Cell Activation through Targeting FIH1.
Li G; Li J; Li C; Qi H; Dong P; Zheng J; Yu F
Cell Physiol Biochem; 2016; 38(4):1544-52. PubMed ID: 27074047
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
[TBL] [Abstract][Full Text] [Related]
8. Elevated miR-129-5p attenuates hepatic fibrosis through the NF-κB signaling pathway via PEG3 in a carbon CCl
Zhu Y; Hu Y; Cheng X; Li Q; Niu Q
J Mol Histol; 2021 Jun; 52(3):491-501. PubMed ID: 33743102
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
10. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression.
Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C
Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797
[TBL] [Abstract][Full Text] [Related]
11. Gant61 ameliorates CCl
Jiayuan S; Junyan Y; Xiangzhen W; Zuping L; Jian N; Baowei H; Lifang J
Toxicol Appl Pharmacol; 2020 Jan; 387():114853. PubMed ID: 31816328
[TBL] [Abstract][Full Text] [Related]
12. Hesperetin derivative attenuates CCl
Chen X; Li XF; Chen Y; Zhu S; Li HD; Chen SY; Wang JN; Pan XY; Bu FT; Huang C; Li J
Int Immunopharmacol; 2019 Nov; 76():105838. PubMed ID: 31473406
[TBL] [Abstract][Full Text] [Related]
13. miR‑375 affects the hedgehog signaling pathway by downregulating RAC1 to inhibit hepatic stellate cell viability and epithelial‑mesenchymal transition.
Liang Z; Li J; Zhao L; Deng Y
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33398380
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-20b-5p Contributes to the Progression of Liver Fibrosis via the STAT3 Signaling Pathway In Vivo and In Vitro.
Lv L; Wang D; Yin J; Yang T; Huang B; Cao Y; Lu J
Dig Dis Sci; 2023 Feb; 68(2):487-496. PubMed ID: 35947307
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of Ezhu-containing serum in inhibiting expression of Shh and Gli1 in hepatic stellate cells].
Feng LL; Cao WF
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):964-969. PubMed ID: 28994542
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑200a suppresses epithelial‑to‑mesenchymal transition in rat hepatic stellate cells via GLI family zinc finger 2.
Yu F; Zheng Y; Hong W; Chen B; Dong P; Zheng J
Mol Med Rep; 2015 Dec; 12(6):8121-8. PubMed ID: 26499180
[TBL] [Abstract][Full Text] [Related]
17. Physalin B attenuates liver fibrosis via suppressing LAP2α-HDAC1-mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation.
Zhu X; Ye S; Yu D; Zhang Y; Li J; Zhang M; Leng Y; Yang T; Luo J; Chen X; Zhang H; Kong L
Br J Pharmacol; 2021 Sep; 178(17):3428-3447. PubMed ID: 33864382
[TBL] [Abstract][Full Text] [Related]
18. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation.
Qu Y; Zhang Q; Cai X; Li F; Ma Z; Xu M; Lu L
J Cell Mol Med; 2017 Oct; 21(10):2491-2502. PubMed ID: 28382720
[TBL] [Abstract][Full Text] [Related]
19. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis.
Lou G; Yang Y; Liu F; Ye B; Chen Z; Zheng M; Liu Y
J Cell Mol Med; 2017 Nov; 21(11):2963-2973. PubMed ID: 28544786
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34b-5p binds enhancer of zeste 2 to inhibit milk fat globule-EGF factor 8 expression, affecting liver fibrosis.
Ma J; Liu Q; Chen M; He B; Li Y; Zhang M; Jiang Y
J Physiol Biochem; 2022 Nov; 78(4):885-895. PubMed ID: 36138295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
